{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"P1M","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","metadata_created":"2019-12-02T14:30:44.615762","subject":["health_and_safety"],"date_modified":"2019-10-25 00:00:00","pspc_identification_number":"","metadata_modified":"2019-12-02T14:30:44.615772","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-12-02","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["La gonorrhée","ITS","ITSS","la tuberculose"],"en":["Gonorrhea","STI","STBBI","tuberculosis"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 45-2/3, le 7 février 2019 : La gonorrhée multirésistante","en":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"25fdac4e-f33c-4e10-87a3-f8ccbff83874","related_relationship":"","name_translated":{"fr":"RMTC : Volume 45-2/3, le 7 février 2019 : La gonorrhée multirésistante","en":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea","language":["en"],"created":"2019-12-02T14:30:51.569443","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019.html","last_modified":null,"position":0,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ed4bc64c-3950-4a6e-8c31-efb9c3c27002","related_relationship":"","name_translated":{"fr":"RMTC : Volume 45-2/3, le 7 février 2019 : La gonorrhée multirésistante","en":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea","language":["fr"],"created":"2019-12-02T14:30:51.569495","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019.html","last_modified":null,"position":1,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"457137e6-c04e-4151-814a-eb4702877071","related_relationship":"","name_translated":{"fr":"RMTC : Volume 45-2/3, le 7 février 2019 : La gonorrhée multirésistante","en":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea","language":["en"],"created":"2019-12-02T14:30:51.569499","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23-eng.pdf","last_modified":null,"position":2,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2e27d93e-8fef-4c53-908f-c3336c304513","related_relationship":"","name_translated":{"fr":"RMTC : Volume 45-2/3, le 7 février 2019 : La gonorrhée multirésistante","en":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea","language":["fr"],"created":"2019-12-02T14:30:51.569501","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23f-fra.pdf","last_modified":null,"position":3,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"398c4681-b912-4837-a6ac-4921a01026ef","related_relationship":"","name_translated":{"fr":"Gonorrhée multirésistante et ultrarésistante, Canada, de 2012 à 2016","en":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016","language":["en"],"created":"2019-12-02T14:30:51.569504","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-1-multidrug-resistant-extensively-drug-resistant-gonorrhea-canada.html","last_modified":null,"position":4,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"171faa80-1b4d-42e5-8078-21bc666f8502","related_relationship":"","name_translated":{"fr":"Gonorrhée multirésistante et ultrarésistante, Canada, de 2012 à 2016","en":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016","language":["fr"],"created":"2019-12-02T14:30:51.569507","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-1-gonorrhee-multiresistante-ultraresistante-canada.html","last_modified":null,"position":5,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"10d5b35f-2225-4dc0-b88d-c67295156708","related_relationship":"","name_translated":{"fr":"Gonorrhée multirésistante et ultrarésistante, Canada, de 2012 à 2016","en":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016","language":["en"],"created":"2019-12-02T14:30:51.569509","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a01-eng.pdf","last_modified":null,"position":6,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4b1b8e44-0016-4664-8d66-76d0f923e906","related_relationship":"","name_translated":{"fr":"Gonorrhée multirésistante et ultrarésistante, Canada, de 2012 à 2016","en":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016","language":["fr"],"created":"2019-12-02T14:30:51.569512","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a01f-fra.pdf","last_modified":null,"position":7,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"89544a47-d94c-4f1e-b90a-02ce386a1ea5","related_relationship":"","name_translated":{"fr":"Prévenir la propagation de la gonorrhée ultrarésistante ","en":"Preventing the spread of extensively drug-resistant gonorrhea"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Preventing the spread of extensively drug-resistant gonorrhea","language":["en"],"created":"2019-12-02T14:30:51.569515","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-2-preventing-spread-drug-resistant-gonorrhea.html","last_modified":null,"position":8,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3629a0e7-ecd0-484d-bcbd-a0335460ecf0","related_relationship":"","name_translated":{"fr":"Prévenir la propagation de la gonorrhée ultrarésistante ","en":"Preventing the spread of extensively drug-resistant gonorrhea"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Preventing the spread of extensively drug-resistant gonorrhea","language":["fr"],"created":"2019-12-02T14:30:51.569517","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-2-prevenir-propagation-gonorrhee-ultraresistante.html","last_modified":null,"position":9,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b0298b41-10d7-4026-b82b-c87a0d6341b9","related_relationship":"","name_translated":{"fr":"Prévenir la propagation de la gonorrhée ultrarésistante ","en":"Preventing the spread of extensively drug-resistant gonorrhea"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Preventing the spread of extensively drug-resistant gonorrhea","language":["en"],"created":"2019-12-02T14:30:51.569520","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a02-eng.pdf","last_modified":null,"position":10,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a34d3ce4-a903-4904-9e07-ec4cea150f2b","related_relationship":"","name_translated":{"fr":"Prévenir la propagation de la gonorrhée ultrarésistante ","en":"Preventing the spread of extensively drug-resistant gonorrhea"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Preventing the spread of extensively drug-resistant gonorrhea","language":["fr"],"created":"2019-12-02T14:30:51.569522","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a02f-fra.pdf","last_modified":null,"position":11,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d5d8a2c6-044b-4e38-8c27-4a86d33987ae","related_relationship":"","name_translated":{"fr":"Avons-nous besoin d’une surveillance intégrée pour évaluer les syndémies d'infections transmissibles sexuellement et par le sang?","en":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?","language":["en"],"created":"2019-12-02T14:30:51.569525","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-3-integrated-surveillance-address-sexually-transmitted-blood-born-syndemics.html","last_modified":null,"position":12,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"18615006-9a88-4f8b-bc21-cc2c73cb394d","related_relationship":"","name_translated":{"fr":"Avons-nous besoin d’une surveillance intégrée pour évaluer les syndémies d'infections transmissibles sexuellement et par le sang?","en":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?","language":["fr"],"created":"2019-12-02T14:30:51.569527","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-3-avons-nous-besoin-une-surveillance-integree-evaluer-syndemies-transmises-sexuellement-ang.html","last_modified":null,"position":13,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"bf6adf15-7b04-468a-a581-99d8fa672058","related_relationship":"","name_translated":{"fr":"Avons-nous besoin d’une surveillance intégrée pour évaluer les syndémies d'infections transmissibles sexuellement et par le sang?","en":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?","language":["en"],"created":"2019-12-02T14:30:51.569530","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a03-eng.pdf","last_modified":null,"position":14,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"90c6f269-9d87-4a2c-b57d-2683dd9acd30","related_relationship":"","name_translated":{"fr":"Avons-nous besoin d’une surveillance intégrée pour évaluer les syndémies d'infections transmissibles sexuellement et par le sang?","en":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics?","language":["fr"],"created":"2019-12-02T14:30:51.569532","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a03f-fra.pdf","last_modified":null,"position":15,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"baf91b5f-171d-4156-bd36-927e2a10d6d3","related_relationship":"","name_translated":{"fr":"La tuberculose au Canada en 2017","en":"Tuberculosis in Canada, 2017"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis in Canada, 2017","language":["en"],"created":"2019-12-02T14:30:51.569535","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-4-tuberculosis-in-canada.html","last_modified":null,"position":16,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5a6c93d9-3441-420b-8268-0d498cc6ba88","related_relationship":"","name_translated":{"fr":"La tuberculose au Canada en 2017","en":"Tuberculosis in Canada, 2017"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis in Canada, 2017","language":["fr"],"created":"2019-12-02T14:30:51.569538","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-4-tuberculose-au-canada.html","last_modified":null,"position":17,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"35ed1aa8-54b1-46e2-8f9a-61fa2e1262e3","related_relationship":"","name_translated":{"fr":"La tuberculose au Canada en 2017","en":"Tuberculosis in Canada, 2017"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis in Canada, 2017","language":["en"],"created":"2019-12-02T14:30:51.569540","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a04-eng.pdf","last_modified":null,"position":18,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b6e4a065-20f6-4048-9f0a-e68e1a849898","related_relationship":"","name_translated":{"fr":"La tuberculose au Canada en 2017","en":"Tuberculosis in Canada, 2017"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis in Canada, 2017","language":["fr"],"created":"2019-12-02T14:30:51.569543","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a04f-fra.pdf","last_modified":null,"position":19,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f22e8958-556f-4cac-8738-b5f6284f1854","related_relationship":"","name_translated":{"fr":"Préparation à la pandémie d'influenza au Canada : Stratégie antivirale","en":"Addressing reluctance to STBBI screening"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Addressing reluctance to STBBI screening","language":["en"],"created":"2019-12-02T14:30:51.569545","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-5-addressing-reluctance-stbbi-screening.html","last_modified":null,"position":20,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a32dd5c6-0255-47b0-8413-1952df18e93c","related_relationship":"","name_translated":{"fr":"Préparation à la pandémie d'influenza au Canada : Stratégie antivirale","en":"Addressing reluctance to STBBI screening"},"hash":"","description":"","format":"HTML","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Addressing reluctance to STBBI screening","language":["fr"],"created":"2019-12-02T14:30:51.569548","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-5-preparation-pandemie-influenza-canada-strategie-antivirale.html","last_modified":null,"position":21,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"07eff851-7178-4482-a777-3687db50766d","related_relationship":"","name_translated":{"fr":"Préparation à la pandémie d'influenza au Canada : Stratégie antivirale","en":"Addressing reluctance to STBBI screening"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Addressing reluctance to STBBI screening","language":["en"],"created":"2019-12-02T14:30:51.569550","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a05-eng.pdf","last_modified":null,"position":22,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6a0246a1-5e74-4618-9a70-519d3b23dfd3","related_relationship":"","name_translated":{"fr":"Préparation à la pandémie d'influenza au Canada : Stratégie antivirale","en":"Addressing reluctance to STBBI screening"},"hash":"","description":"","format":"PDF","date_published":"2019-02-07","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Addressing reluctance to STBBI screening","language":["fr"],"created":"2019-12-02T14:30:51.569553","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a05f-fra.pdf","last_modified":null,"position":23,"revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7","resource_type":"website"}],"place_of_publication":[],"num_resources":24,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2019-02-07 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"7ab915a5-0d6a-4b88-98dd-79d5edddd3eb","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea","revision_id":"c674aa98-94a8-42d1-a318-f7fddaab6af7"}